Skip to content
PICO Portalanswers from OpenAlex

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

PaperCitations, authors & open-access status

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is a paper indexed in PICO Portal from OpenAlex.

How many citations does Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma have?

PICO Portalcitation count

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma has 366 citations in the OpenAlex counts PICO Portal stores.

When was Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma published?

PICO Portalyear

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma has 2018 year in the PICO Portal index.

What is the open-access status of Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?

PICO Portaloa status

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma has bronze oa status in the PICO Portal index.

What is the DOI of Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?

PICO Portaldoi

The DOI for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is on the source record.

What is the PMID of Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?

PICO Portalpmid

The PMID for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is on the source record.

What is the OpenAlex record for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?

PICO Portalopenalex

The OpenAlex for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial